A fluorescence-activated cell sorter screening method has been used to identify hybridomas that secrete monoclonal antibodies that can bind to viable subpopulations of embryonic chicken neural retina cells. One monoclonal antibody, C1H3, recognizes two nervous tissue-specific polypeptides that exhibit distinct developmental patterns. The monoclonal antibody reacts with a 140-kilodalton (kDa) polypeptide that is present at early stages of development (day 7) but is detected by immunoblotting in only negligible amounts at later times (day 17). In contrast, a 170-kDa polypeptide is first detectable by immunoblotting at day 10 and is the predominant CjH3 antigen at day 17. Analysis of proteolytic fragments of the two proteins indicates that the polypeptides are distinct molecules that share a common antigenetic determinant. Both polypeptides are neural-specific; the 140-kDa polypeptide appears to be retina-specific, while the 170-kDa polypeptide is also present in other areas of the nervous system. Metabolic labeling of retina cells in situ at early embryonic stages reveals only the synthesis of the 140-kDa polypeptide. When such cells are dissociated and labeled in vitro, they synthesize primarily the 170-kDa polypeptide. Thus, the differential rate of synthesis of these two polypeptides is controlled by environmental factors that possibly include cell-cell contacts or an unknown systemic factor. The 140-kDa polypeptide is a unique marker for early neural retina cells.
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A goal of current research in neurobiology is the characterization of the molecular composition of defined cell types. The primary aim of these studies is to identify specific cell surface macromolecules that may serve as probes for the study of cell recognition phenomena or cell differentiation. Of particular interest is the search for molecules that may be specific to only a single cell type, thus providing the opportunity to follow the progress of the cells during development. The application of immunological techniques has facilitated the search for these unique neural cell markers, particularly after the advent of the hybridoma technology of Kohler and Milstein (for a general review, see ref. 1 ). Recent studies using monoclonal antibodies (MAbs) have described neuralspecific markers in cerebellum (2) (3) (4) (5) , spinal cord (6, 7) , and neural retina (8) (9) (10) . MAbs also have been used to identify the neuron-specific A2B5 ganglioside (11) , oligodendrocyte antigens (12) , and central nervous system-specific (13) and peripheral nervous system-specific (14) antigens.
As part of a broad program to identify and characterize cell-specific surface antigens in the chicken neural retina, we identified two novel antigens with a MAb designated C1H3. Both of these proteins, which appear to be distinct, are localized exclusively in the embryonal nervous system. The first antigen, a polypeptide of 140 kilodaltons (kDa), is unique to early retinal cells and is present on the surface of 70% of dissociated retina cells. To the best of our knowledge, no antigen that is uniquely localized to the early retina has been previously described. The second polypeptide, of size 170 kDa, is common to all neuronal tissue examined. However, it only accumulates late in development in the neural retina, concomitant with the diminished expression of the 140-kDa protein. We report here the characterization of these two polypeptides as distinct proteins and describe their developmental regulation in the neural retina.
MATERIALS AND METHODS
Preparation and Screening of MAbs. MAbs were prepared by the method of Galfre et al. (15) as described (16) . Briefly, day 7 retinas were mechanically dissociated, and the intact cells were injected intravenously into the tail vein of Sprague-Dawley rats. Hybridomas secreting antibodies against subpopulations of embryonic chicken retina cells were screened by using a fluorescence-activated cell sorter (FACS) method developed in this laboratory (16) . Briefly, mechanically dissociated retina cells from day 9 retina were cultured in Costar microtiter plates for 2-3 hr, followed by a 1-hr incubation with culture supernatants containing MAbs. Cells were then labeled with fluorescein-conjugated goat anti-rat IgG (Cappel Laboratories, Cochranville, PA) and identified in a FACS IV (Becton Dickinson, Sunnyvale, CA), equipped with a logarithmic amplifier. Positive clones were recloned by using the FACS, and MAbs were isolated either by saturated ammonium sulfate precipitation of culture medium or from ascites fluid obtained after growing hybridomas in BALB/c nude mice.
Immunocytochemical Localization of Antigens. Immunocytochemical localization of antibody binding was performed on 10-pm cryostat sections of retina fixed in periodate/lysine/paraformaldehyde (9) by the unlabeled enzyme method of Sternberger (17) . Sections were incubated with culture supernatants and visualized by incubation with unlabeled goat anti-rat IgG and rat peroxidase-antiperoxidase (Pel-Freez) and by reaction with 3,3'-diaminobenzidine. Sec min, followed by transfer to media containing 2 mM Lmethionine for the times indicated. After labeling, cells were washed three times in Hanks' balanced salt solution and homogenized in 0.4 ml of immunoprecipitation buffer (150 mM NaCl/20 mM Na2HPO4/1% Triton X-100/1% sodium deoxycholate/0.1% NaDodSO4/1 mM benzamidine HCl/0.3 mM phenylmethylsulfonyl fluoride/1.0 mM methionine, pH 7.5) as described (19) .
[35S]Methionine incorporation was quantitated by precipitation of an aliquot of the homogenate in 10% trichloroacetic acid at 4°C for 30 min. Trichloroacetic acid-precipitable material then was collected by filtration on DA filters (Millipore) and washed twice with 5% trichloroacetic acid and once with absolute ethanol. C1H3 antigen(s) was immunoprecipitated according to published methods (19) . Briefly, homogenates were incubated at 4°C with appropriate dilutions of ammonium sulfateprecipitated MAb and were precipitated with goat anti-rat IgG-coated Staphylococcus aureus cells (Bethesda Research Laboratories). Then the isolated S. aureus cells were suspended in 50 ,ul of electrophoresis sample buffer and heated to 100'C for 5 min; immunoprecipitated polypeptides were analyzed by NaDodSO4/polyacrylamide gel electrophoresis.
For peptide mapping of C1H3 antigens, dissociated cells were labeled with [75Se]selenomethionine as described (this radioactive precursor was used because of its high energy of emission and, thus, greater sensitivity in peptide mapping), followed by immunoprecipitation and polyacrylamide gel electrophoresis. Bands were identified by autoradiography, cut from the gel, and incubated overnight at 37°C with 300 pg of subtilisin BPN' protease (Sigma) in 0.05 M NH4HCO3 (pH 8.0) as described (20) . The amount of protease used for digestion was in excess of substrate and therefore ensured complete digestion of the C1H3 antigens. Peptide fragments were then separated by HPLC on a Waters C18 micro bonded column using a 0-60%o gradient of acetonitrile programmed at 0.5%/min. Fractions (0.5 min) were collected and counted in a Beckman gamma counter.
RESULTS
In order to identify antigens present on the cell surface of retina cells that are viable in culture, our laboratory has developed a simple screening method using a FACS (16) . One advantage of this method is that MAbs can be readily identified that bind to subpopulations of retina neurons. Because the antigen is restricted to the cell surface, it should be possible to isolate the subpopulations of cells and to maintain them in culture, thus permitting a more detailed biochemical analysis of the cells than can be obtained in vivo. In the present study, we concentrated on a single MAb identified by using the FACS screening protocol. The MAb C1H3 reacts with the majority of retina neurons (70% of total cells) as demonstrated by FACS analysis (Fig. 1) . It can be seen in antigenic sites exist for C1H3 on the cell surface.
The localization of the C1H3 antigen to specific cell layers of the retina was determined by immunoperoxidase staining (Fig. 2) . The distribution of the antigen in immature retina (day 7) is shown in Fig. 2a . The MAb appeared to stain most cell types at this age (in agreement with FACS analysis), particularly the ganglion cells. This conclusion is based on the pronounced staining of the most vitreal surface of the retina, which has been shown to contain the ganglion cells and the developing nerve fiber layer (21) . In day 12 retina (Fig. 2b) Sections were then incubated with goat anti-rat whole serum (1:10) and peroxidase-antiperoxidase (1:100). MAb binding was visualized by reaction with 0.05% 3,3'-diaminobenzidine and 0.01% hydrogen peroxide in 0.05 M Tris-HCl (pH 7.4). Note that most cells are labeled to varying extents at all ages; however, the most apparent developmental difference in staining is observed in the nerve fiber layer at days 7 and 12 relative to day 19. ONL, outer nuclear layer; OPL, outer plexiform layer; INL, inner nuclear layer; IPL, inner plexiform layer; GCL, ganglion cell layer; NFL, nerve fiber layer. Neurobiology: Cole and Glaser greatest intensity. In contrast, the inner nuclear and ganglion cell layers showed only light staining. By embryonic day 19 ( Fig. 2c) , the pattern of staining was relatively unchanged, except that the intensity of staining of the nerve fiber layer had decreased when compared to day 12. This result may imply that there is an altered distribution of the CjH3 antigen in retina as the developing retina matures because with increasing age there would be an augmented concentration of neural membrane in the nerve fiber level and, hence, an anticipated increase in staining at day 19. These data also indicate that the C1Hj antigen is enriched in ganglion cell bodies and processes in early retina but is distributed more evenly in the fiber layers as the tissue matures. It was also apparent in day 19 retina that the inner nuclear and ganglion cell layers show low-level staining and that the outer nuclear and photoreceptor layers are not stained. The antigen recognized by the C1H3 MAb was identified by immunoblotting of electrophoretically separated retina cell proteins. Fig. 3 shows the results of immunoblotting of protein extracts from embryonic day 9 retina and from other neural and nonneural tissues. In day 9 retina the CjH3 MAb reacted with a 140-kDa polypeptide. In contrast, in day 9 brain or tectum and in day 11 sympathetic ganglia, the antibody recognized a 170-kDa protein. The CjH3 MAb did not react with any polypeptide species in day 9 liver, heart, or fibroblasts (Fig. 3) or with any component in day 6 liver and heart or day 9 11 sympathetic ganglia; e, day 9 liver; f, day 9 skin fibroblasts; g, day 9 heart. Sizes are shown in kDa. Protein standards included myosin heavy chain (200 kDA), 3-galactosidase (116.5 kDa), and phosphorylase b (92 kDa). present in retina (Fig. 4a) . By day 12 a significant amount of the 170-kDa polypeptide could be detected, in addition to the antigen of lower molecular size. By day 17 our results showed that the predominant C1H3 antigen in retina is the 170-kDa species.
We also carried out similar developmental studies using protein obtained from optic tectum and brain of the developing chicken embryo. Brain at all developmental stages contained only the 170-kDa antigen (Fig. 4b) . The optic tectum also contained this antigen at all developmental stages; however, between days 12 and 17, the 140-kDa form of the antigen was present also in low amounts in the optic tectum. In light of evidence indicating that a small number of ganglion cell fibers begin to innervate the tectum at day 6, with the majority of fibers reaching the tectum at days 10-12 (22) , it is likely that the 140-kDa component is only found in optic tectum as a result of innervation by ganglion cell axons.
Analysis of the C1H3 antigens by immunoblotting did not clarify the relationship between the 140-and 170-kDa polypeptides. Therefore, additional studies were necessary to gain insight into the relationship between these molecules. For example, the 140-kDa protein could arise from the 170-kDa polypeptide by proteolytic cleavage or the 170-kDa protein could arise from the 140-kDa protein by extensive glycosylation. In order to ascertain if the 140-and 170-kDa polypeptides are structurally related proteins (differing only as a result of processing) or if the polypeptides are distinct molecules sharing a common antigenic determinant, retina cells were metabolically labeled and the two antigens were isolated by immunoprecipitation and characterized as described below. (Fig. Sa) . Labeling of trypsin-dissociated or mechanically dissociated day 7 retina cells surprisingly also showed that the 170-kDa polypeptide was the major C1H3 reactive antigen detected, although small amounts of the 140-kDa protein also were synthesized (Fig. 5b) Proc. NatL Acad Sci. USA 81 (1984) .41 .* 0,':z .0 Proc. Natl. Acad. Sci. USA 81 (1984) which measure the rate of antigen synthesis, could be due to changes in the biosynthetic program induced by cell dissociation. To test this possibility, retinas were labeled in vivo. Under these conditions only the 140-kDa polypeptide was detected by immunoprecipitation of the radioactive cells (Fig. 5d ). This observation indicates that day 7 retina has the potential of synthesizing the 170-kDa protein but it does not accumulate in the cells in detectable amounts. One possible explanation for these results is that the 170-kDa protein is a precursor of the 140-kDa protein and that post-translational modification of the polypeptide is not completed in dissoci- (Fig. 5e) .
A precursor-product relationship between these two antigenically related proteins would be precluded if the proteins were found to be largely distinct by peptide mapping. Fig. 6 shows peptide maps obtained by HPLC of [75Se]selenomethionine-labeled C1H3 antigens isolated by immunoprecipitation. The absence of pronounced similarities in the elution pattern of the peptide fragments in Fig. 6 demonstrates conclusively that the 140-and 170-kDa polypeptides are distinct proteins that share a common antigenic determinant.
DISCUSSION
To the best of our knowledge an antigen that uniquely identifies cells at early stages of development in the chicken neural retina (or retinas of other species) has not been described. The results described in this study strongly suggest that the 140-kDa protein identified in early neural retina represents such a cell surface marker. While the C1H3 MAb recognizes a second polypeptide present in nervous tissue, the two polypeptides appear to be distinct molecules that are not biosynthetically related but share an antigenic determinant. The recognition of several distinct proteins by one MAb has been documented (23, 24) . The apparent change in histological staining of the antigens recognized in neural retina by C1H3 also suggests that the 140-and 170-kDa polypeptides have different cellular distributions or, at least, are present in the same cell types but in different concentrations. For example, the apparent reduction of immunoperoxidase staining in the nerve fiber layer (Fig. 2 b and c) is also temporally correlated with the shift in appearance of the two antigens.
Analysis of the developmental expression of the two antigens in brain and tectum suggests that the 140-kDa polypep-FRACTION NUMBER FIG. 6 . Analysis of peptide fragments of C1H3 antigens by HPLC. Immunoprecipitated C1H3 antigens were separated on 5% polyacrylamide gels and visualized by autoradiography, and then the bands were cut from the gel. The polypeptides were then treated with 300 ,ug of subtilisin BPN protease as described. Peptide fragments were separated on a Waters C18 micro bonded column with a 0.5%/min gradient of acetonitrile. Individual fractions (0.5 min) were graphed with respect to radioactivity: *, 170-kDa polypeptide; o, 140-kDa polypeptide.
tide is retina-specific. Small quantities of the 140-kDa polypeptide are detected in the optic tectum; however, expression of this antigen in the tectum strongly suggests that it only appears in the tectum after innervation by retina ganglion cell axons. To unequivocally demonstrate that the 140-kDa protein is retina-specific, it will be necessary to show that the expression of the molecule in the tectum is dependent on innervation by ganglion cell axons. Disruption of innervation by removal of the optic cup should indicate if such a dependence exists.
Although the function of the two ClH3-reactive polypeptides is unknown, their expression during development implies that their functions are also distinct. At the present time, we can only speculate on the possible function of these molecules. The presence of a cell surface marker that uniquely identifies early retina cells directly leads to the postulate that this molecule participates in cell recognition processes and/or in the identification of retinal cells as a distinct subpopulation of differentiating cells. It should be feasible in the future to select monoclonal antibodies that only recognize the 140-kDa polypeptide and to use these antibodies to assess the function of this protein by impairing normal development. The highly restricted cellular localization of the 140-kDa antigen also should permit studies aimed at the delineation of the appearance and migration of presumptive neural retina cells from the primitive ectoderm of the developing chicken embryo.
The broad distribution of the 170-kDa polypeptide does not provide any obvious clues regarding the role of this nervous tissue-specific antigen in neural retina development. Immunocytochemical localization of the 170-kDa polypeptide during late stages of development has shown that it is enriched in the nerve fiber and plexiform layers, which suggests that the molecule could be localized to synapses. In the light of the demonstration that in vitro the 170-kDa polypeptide is secreted by retinal cells, one may speculate that this molecule functions in cell adhesion systems. This proposal is based on evidence that other cell adhesion molecules, such as N-CAM (25) and D2 (26) , have been shown to be released from the cell surface. In addition, a polypeptide of similar molecular size is present in embryonic chicken retinal cell adherons (27) .
